BDBM349709 2-[(4-{6-[(4-Cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 5A-01
SMILES: OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2c1
InChI Key: InChIKey=MHGRIBXIKDJHKB-QHCPKHFHSA-N
Data: 2 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349709 (2-[(4-{6-[(4-Cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.40 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349709 (2-[(4-{6-[(4-Cyano-2-fluorobenzyl)oxy]pyridin-2-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.340 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair |